Ginsenoside Rb1

Pharmacology & Research

Ginsenoside Rb1 is the dominant protopanaxadiol (PPD) saponin of Asian ginseng (Panax ginseng), where it typically sits at around 5.8 mg/g of root and is often the single most abundant ginsenoside present. The relative amount of Rb1 versus the protopanaxatriol saponin ginsenoside Rg1 is one of the chemical fingerprints used to tell Panax ginseng (PPD-rich, higher Rb1:Rg1) from Panax quinquefolius (American ginseng). Rb1 carries a very large preclinical literature — neuroprotection in models of cerebral ischemia, cardioprotection against ischemia-reperfusion injury, and effects on glucose uptake and insulin sensitivity — almost all of it in cells or rodents ^{1Reference 1Dong X et al. · 2017AnimalNeuroprotective effects of pretreatment of ginsenoside Rb1 on severe cerebral ischemia-induced injuries in aged mice: involvement of anti-oxidant signaling — mouse, in vivoView study →2Reference 2Liu JW et al. · 2013AnimalEffect of ginsenoside Rb1 on cerebral infarction volume and IL-1 beta in brain tissue and sera of focal cerebral ischemia/reperfusion injury model rats — rat, in vivo animal modelView study →6Reference 6Li YH et al. · 2016AnimalCardioprotection of ginsenoside Rb1 against ischemia/reperfusion injury is associated with mitochondrial permeability transition pore opening inhibition — rat, in vivo animal modelView study →7Reference 7Wang Z et al. · 2008AnimalGinsenoside Rb1 preconditioning protects against myocardial infarction after regional ischemia and reperfusion by activation of phosphatidylinositol-3-kinase signal transduction — rat, in vivo animal modelView study →8Reference 8Shang WB et al. · 2014In vitroGinsenoside Rb1 upregulates expressions of GLUTs to promote glucose consumption in adipocytes — in vitroView study →9Reference 9Shen L et al. · 2015AnimalGinsenoside Rb1 increases insulin sensitivity by activating AMP-activated protein kinase in male rats — rat, in vivo animal modelView study →}. The critical caveat runs through everything below: isolated Rb1 is barely absorbed when taken by mouth (rat oral bioavailability around 4% or lower), and gut microbiota convert it into compound K, the metabolite that actually reaches the blood in quantity ^{10Reference 10Xu QF et al. · 2003AnimalPharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats — rat, in vivo pharmacokineticsView study →11Reference 11Kang A et al. · 2016AnimalGut microbiota in the pharmacokinetics and colonic deglycosylation metabolism of ginsenoside Rb1 in rats: contrary effects of antimicrobials treatment and restraint stress — rat, in vivo animal modelView study →}. Ginseng’s clinical reputation rests on whole-extract human data, not on isolated Rb1.

1. Neuroprotection (cerebral ischemia)

This is the strongest Rb1-specific signal. In rat middle-cerebral-artery-occlusion (MCAO) models, isolated Rb1 (dosed 20–80 mg/kg by injection) reduced infarct volume, improved neurologic scores, and lowered brain and serum IL-1β ^{2Reference 2Liu JW et al. · 2013AnimalEffect of ginsenoside Rb1 on cerebral infarction volume and IL-1 beta in brain tissue and sera of focal cerebral ischemia/reperfusion injury model rats — rat, in vivo animal modelView study →}. Pretreatment with oral Rb1 dose-dependently protected aged mice against severe cerebral ischemia through antioxidant signalling ^{1Reference 1Dong X et al. · 2017AnimalNeuroprotective effects of pretreatment of ginsenoside Rb1 on severe cerebral ischemia-induced injuries in aged mice: involvement of anti-oxidant signaling — mouse, in vivoView study →}, and mechanistic rat work links Rb1’s hippocampal protection to Akt/mTOR/PTEN signalling ^{4Reference 4Guo Y et al. · 2018AnimalEffects of ginsenoside Rb1 on expressions of phosphorylation Akt/phosphorylation mTOR/phosphorylation PTEN in artificial abnormal hippocampal microenvironment in rats — rat, in vivoView study →}. A broader review places Rb1 among the more active neuroprotective ginsenosides against cerebral ischemia ^{3Reference 3Cheng Z et al. · 2019ReviewNeuroprotective effects of ginsenosides against cerebral ischemia — reviewView study →}.

Gap: every study uses isolated Rb1 in rodents, often by injection to bypass poor oral uptake; there are no human trials of the isolated compound, and how much protection survives first-pass conversion to compound K after oral dosing is unknown.

2. Cardioprotection

Isolated Rb1 has repeatedly protected heart tissue in ischemia-reperfusion models. In rats, Rb1 limited ischemia-reperfusion injury in a way associated with inhibition of mitochondrial permeability transition pore opening ^{6Reference 6Li YH et al. · 2016AnimalCardioprotection of ginsenoside Rb1 against ischemia/reperfusion injury is associated with mitochondrial permeability transition pore opening inhibition — rat, in vivo animal modelView study →}, and Rb1 preconditioning reduced myocardial infarct size after regional ischemia through PI3K/Akt signal transduction ^{7Reference 7Wang Z et al. · 2008AnimalGinsenoside Rb1 preconditioning protects against myocardial infarction after regional ischemia and reperfusion by activation of phosphatidylinositol-3-kinase signal transduction — rat, in vivo animal modelView study →}. Effects are consistent across models but sit entirely at the cell- and rodent-mechanism level.

Gap: all isolated-Rb1, all preclinical, and mostly delivered by injection or direct application; no clinical cardiovascular endpoints for the isolated molecule.

3. Glucose uptake & insulin sensitivity

Isolated Rb1 stimulates glucose handling through two documented routes. In 3T3-L1 adipocytes it up-regulated glucose transporters (GLUTs) and promoted glucose consumption in vitro ^{8Reference 8Shang WB et al. · 2014In vitroGinsenoside Rb1 upregulates expressions of GLUTs to promote glucose consumption in adipocytes — in vitroView study →}. In male rats, a short course of Rb1 improved glucose tolerance and increased insulin sensitivity, with the mechanism traced to activation of AMP-activated protein kinase (AMPK) ^{9Reference 9Shen L et al. · 2015AnimalGinsenoside Rb1 increases insulin sensitivity by activating AMP-activated protein kinase in male rats — rat, in vivo animal modelView study →}.

Gap: in vitro plus short-term rat studies with isolated Rb1; no diabetic clinical outcomes, and the poor oral bioavailability again complicates translation to an oral human dose.

4. Anti-inflammatory / mood

Isolated Rb1 shows anti-inflammatory activity in the brain in rodent models. In male mice exposed to chronic mild stress, Rb1 induced a pro-neurogenic microglial phenotype via PPARγ activation and eased depressive-like behaviour ^{5Reference 5Zhang L et al. · 2021AnimalGinsenoside Rb1 induces a pro-neurogenic microglial phenotype via PPARγ activation in male mice exposed to chronic mild stress — mouse, animal modelView study →}; anti-inflammatory effects in ischemia models also involve suppression of NF-κB-driven cytokines ^{2Reference 2Liu JW et al. · 2013AnimalEffect of ginsenoside Rb1 on cerebral infarction volume and IL-1 beta in brain tissue and sera of focal cerebral ischemia/reperfusion injury model rats — rat, in vivo animal modelView study →}. This overlaps with ginseng’s traditional adaptogen reputation — but that reputation is built on whole-extract use, not isolated Rb1.

Gap: rodent behavioural and neuroinflammation models only; no human data for isolated Rb1, and mood/cognitive claims for “ginseng” are whole-plant, not attributable to Rb1 specifically.

Mechanisms

Target / pathway	Effect	Relevant to
PI3K/Akt (± mTOR, PTEN)	Pro-survival signalling; anti-apoptotic	Neuroprotection, cardioprotection 4Reference 4Guo Y et al. · 2018AnimalEffects of ginsenoside Rb1 on expressions of phosphorylation Akt/phosphorylation mTOR/phosphorylation PTEN in artificial abnormal hippocampal microenvironment in rats — rat, in vivoView study →7Reference 7Wang Z et al. · 2008AnimalGinsenoside Rb1 preconditioning protects against myocardial infarction after regional ischemia and reperfusion by activation of phosphatidylinositol-3-kinase signal transduction — rat, in vivo animal modelView study →
Mitochondrial permeability transition pore	Inhibits opening; preserves mitochondria	Cardioprotection 6Reference 6Li YH et al. · 2016AnimalCardioprotection of ginsenoside Rb1 against ischemia/reperfusion injury is associated with mitochondrial permeability transition pore opening inhibition — rat, in vivo animal modelView study →
NF-κB / IL-1β, TNF-α, IL-6	Suppresses pro-inflammatory cytokines	Neuroprotection, anti-inflammatory 2Reference 2Liu JW et al. · 2013AnimalEffect of ginsenoside Rb1 on cerebral infarction volume and IL-1 beta in brain tissue and sera of focal cerebral ischemia/reperfusion injury model rats — rat, in vivo animal modelView study →
AMP-activated protein kinase (AMPK)	Activation; improves insulin sensitivity	Glucose handling 9Reference 9Shen L et al. · 2015AnimalGinsenoside Rb1 increases insulin sensitivity by activating AMP-activated protein kinase in male rats — rat, in vivo animal modelView study →
GLUT1 / GLUT4	Increased expression / translocation	Glucose uptake 8Reference 8Shang WB et al. · 2014In vitroGinsenoside Rb1 upregulates expressions of GLUTs to promote glucose consumption in adipocytes — in vitroView study →
PPARγ (microglia)	Activation; pro-neurogenic microglial phenotype	Anti-inflammatory / mood 5Reference 5Zhang L et al. · 2021AnimalGinsenoside Rb1 induces a pro-neurogenic microglial phenotype via PPARγ activation in male mice exposed to chronic mild stress — mouse, animal modelView study →
Gut microbiota (β-glucosidases)	Deglycosylation of Rb1 → compound K	Pharmacokinetics; bioactivation 11Reference 11Kang A et al. · 2016AnimalGut microbiota in the pharmacokinetics and colonic deglycosylation metabolism of ginsenoside Rb1 in rats: contrary effects of antimicrobials treatment and restraint stress — rat, in vivo animal modelView study →

Pharmacokinetics

Bioavailability is the load-bearing fact for Rb1. Absolute oral bioavailability in rats is very low — on the order of 4.35% in one classic determination, and often cited lower still — because the large, polar saponin is poorly absorbed intact across the gut wall ^{10Reference 10Xu QF et al. · 2003AnimalPharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats — rat, in vivo pharmacokineticsView study →}. What reaches the systemic circulation in meaningful quantity is largely its gut-microbiota metabolite: colonic bacteria progressively deglycosylate Rb1 (Rb1 → Rd → F2 → compound K), and compound K is the more absorbable, often more potent active ^{11Reference 11Kang A et al. · 2016AnimalGut microbiota in the pharmacokinetics and colonic deglycosylation metabolism of ginsenoside Rb1 in rats: contrary effects of antimicrobials treatment and restraint stress — rat, in vivo animal modelView study →}. This microbiota dependence means exposure varies widely between individuals and is blunted by antibiotics; it also reframes the enormous preclinical body, much of which uses injected Rb1 to bypass the gut entirely ^{11Reference 11Kang A et al. · 2016AnimalGut microbiota in the pharmacokinetics and colonic deglycosylation metabolism of ginsenoside Rb1 in rats: contrary effects of antimicrobials treatment and restraint stress — rat, in vivo animal modelView study →}. Circulating Rb1 itself is cleared slowly, with a relatively long terminal half-life reported across rodent studies ^{10Reference 10Xu QF et al. · 2003AnimalPharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats — rat, in vivo pharmacokineticsView study →}.

Clinical trials

There are essentially no registered clinical trials of the isolated compound — human evidence associated with ginsenoside Rb1 comes from whole-Panax ginseng extracts standardised to total ginsenosides, not from Rb1 given alone, so benefits cannot be attributed to Rb1 specifically.

Last checked: July 2026.

Toxicity & Safety

Ginsenoside Rb1 is regarded as low in toxicity at the levels supplied by normal ginseng use, and it is one of the best-tolerated ginsenosides in animal work ^{3Reference 3Cheng Z et al. · 2019ReviewNeuroprotective effects of ginsenosides against cerebral ischemia — reviewView study →}. The main practical cautions attach to whole ginseng rather than the isolated saponin: possible additive effects on blood glucose (relevant alongside anti-diabetic drugs, given Rb1’s insulin-sensitising signal) ^{9Reference 9Shen L et al. · 2015AnimalGinsenoside Rb1 increases insulin sensitivity by activating AMP-activated protein kinase in male rats — rat, in vivo animal modelView study →}, and the general ginseng cautions around stimulation and anticoagulant/antiplatelet interactions. The one specific isolated-Rb1 safety signal worth flagging is developmental: in a whole-rat-embryo culture model, Rb1 was teratogenic to rat embryos at high concentrations in vitro ^{12Reference 12Chan LY et al. · 2003In vitroAn in-vitro study of ginsenoside Rb1-induced teratogenicity using a whole rat embryo culture model — in vitroView study →}. This is an in-vitro finding at supraphysiologic exposure, not evidence of harm from dietary ginseng.

Dosage

There is no established human dose for isolated ginsenoside Rb1; it is a research compound, not a standardised supplement. For orientation only, the preclinical exposures cited above were rodent doses — for example cerebral-ischemia rat studies used roughly 20–80 mg/kg of Rb1 by injection ^{2Reference 2Liu JW et al. · 2013AnimalEffect of ginsenoside Rb1 on cerebral infarction volume and IL-1 beta in brain tissue and sera of focal cerebral ischemia/reperfusion injury model rats — rat, in vivo animal modelView study →}, and metabolic rat studies used short courses of oral Rb1 ^{9Reference 9Shen L et al. · 2015AnimalGinsenoside Rb1 increases insulin sensitivity by activating AMP-activated protein kinase in male rats — rat, in vivo animal modelView study →} — routes and doses chosen partly to work around Rb1’s poor oral absorption. None of these translate directly to a human oral dose, and human ginseng intake is taken as whole standardised extract, not isolated Rb1. These are doses studied in research and are not a personal recommendation.

References